Financing the Footprint: Why Real Estate Strategy Has to Align with Your CFO
How you finance a clinic build-out is a capital-structure decision, not an administrative one. Match the cheapest appropriate capital to each category of spend: landlord TIA for fixed improvements, equipment and debt financing for recoverable assets, and reserve expensive equity for growth. Defaulting to equity or an oversized TIA quietly raises your cost of capital and suppresses EBITDA for years.
Most founders think about dilution when they raise money, and understandably so: dilution is explicit. It's negotiated, modeled, and discussed at the board level. But a quieter version of the same issue shows up inside the real estate process, where financing decisions get made without the same scrutiny.
Once a healthcare company moves from finding a site to building a clinic, real estate stops being just a location decision and becomes a capital allocation decision. The question is no longer whether the team can get the doors open. It's what source of capital is being consumed, what that capital actually costs, and what the structure does to the economics of the site after opening.
A clinic is a physical asset, but the lease and build-out strategy behind it function as a capital structure decision that affects cost of capital, EBITDA, and enterprise value.
Why do founders overlook how they finance the build-out?
In most early-stage healthcare companies, the care model gets the strategic attention and the site gets the tactical attention. The financing of the footprint gets treated as an administrative problem to solve on the way to opening. That's where the mistake starts.
The same clinic can be funded several ways. You can lean heavily on landlord capital, use equity, finance equipment and other recoverable assets, or combine those tools more deliberately. Each approach changes control, timing, flexibility, and long-term operating cost. So the financing structure isn't downstream from the real estate strategy. It's part of the strategy.
The goal isn't just to finance the clinic. It's to use the cheapest appropriate capital for each part of the build-out without weakening the business that has to operate inside it.
This is why real estate has to align with the CFO. If finance is focused on preserving runway, improving capital efficiency, and protecting valuation, real estate can't run as a separate workstream focused only on rent and concessions. Those decisions are connected; they just show up in different lines of the model.
How should you finance a clinic build-out?
TIA can preserve cash, but it's rarely free
A large tenant improvement allowance can be useful. It reduces near-term cash needs and can make a project easier to launch, which matters for a growing company. But the allowance usually isn't free capital. It's capital embedded into the lease and repaid over time through occupancy cost.
That distinction matters because teams celebrate the size of the TIA without fully modeling the rent burden, the lease term, or the execution constraints attached to it. A landlord isn't a neutral capital partner; they're pricing risk, return, and control into the deal. Sometimes that structure works well, and sometimes it quietly becomes one of the more expensive parts of the project. There's also a practical issue: landlord-controlled or poorly documented reimbursement structures can reduce speed and flexibility when conditions change during construction. So the question isn't whether the allowance is high. It's whether it's worth the operating and financial tradeoffs attached to it.
Equity is clean operationally and expensive financially
Using venture or private equity capital to fund the build-out feels clean: it avoids lender friction and keeps control. In a fast-moving startup, that simplicity is appealing. But it also means the business is spending its most expensive capital on improvements that don't carry the same return profile as growth investments.
This is where dilution still belongs in the conversation, even when cost of capital is the primary frame. Founders may not be issuing new shares to build the clinic, but they're making a dilution-adjacent choice when they spend high-cost equity on walls, flooring, and electrical instead of preserving it for patient acquisition, team build-out, or operating systems. The effect is quieter, but the strategic damage can be real.
Specialized financing is often the most rational tool
Debt and equipment financing are often underused in healthcare expansion, especially for assets a lender can clearly define and recover. Imaging equipment, dental chairs, technology systems, and other movable components are usually far better fits for specialized financing than fixed improvements tied to the shell.
That lets the capital stack be designed with discipline. TIA can support part of the fixed build-out, equipment financing can support recoverable assets, and equity can be reserved for growth and operating uses where it earns a better strategic return. The point isn't to maximize leverage. It's to match the right capital source to the right spend category.
Why does a transactional broker miss this?
This is where the difference between transactional brokerage and strategic healthcare real estate gets obvious. A transactional process optimizes for lease execution: get the document signed, maximize the visible concession package, move the project forward. That can be enough to complete a deal. It isn't enough to protect the economics of a growing healthcare business.
Transactional logic
Maximize the headline TIA, minimize visible out-of-pocket cost, and treat the signed lease as the finish line.
Capital-aligned logic
Evaluate the lease, financing mix, and build-out structure on their long-term effect on margin, flexibility, and enterprise value.
For founders and CFOs, the lease isn't the end of the conversation. It's the mechanism through which capital gets deployed into the footprint, so every concession has to be tested against what it does to rent, timing, draw control, and long-term operating performance.
Small lease decisions, large valuation consequences
Don't evaluate a financing structure only on upfront cash preservation. Evaluate it against EBITDA and exit value too.
- An extra $5,000 per month in rent reduces annual EBITDA by $60,000.
- At a 10x to 15x multiple, that's roughly $600,000 to $900,000 of enterprise-value pressure.
- A "good" concession package can still be a bad capital decision if it weakens unit economics for years.
How should real estate plug into the capital stack?
The better question isn't "How do we pay for this build-out?" It's "How should this site be financed given our broader capital strategy?" That framing forces the founder, COO, and CFO to evaluate the project as one coordinated system instead of three separate conversations.
The founder is protecting the vision and growth path. The COO is protecting workflows and launch readiness. The CFO is protecting the math. Real estate sits in the middle, because it translates all three into a physical and financial structure the business will live with for years. In practice that means negotiating TIA that doesn't break the unit economics, aligning construction cash needs with fundraising timing, and preserving lease flexibility for equipment financing and future changes. Once those constraints are embedded in the lease, they're expensive to undo.
Key takeaways
- Financing the footprint is a capital-structure decision: match the cheapest appropriate capital to each spend category instead of defaulting to equity or a big TIA.
- A TIA isn't free. It's lease-embedded capital repaid through rent, so model the rent burden, term, and draw control, not just the headline number.
- Equity is operationally clean but financially expensive; spending it on walls and flooring is a dilution-adjacent choice that starves patient acquisition and growth.
- Equipment and debt financing fit recoverable assets (imaging, chairs, technology); reserve equity for growth and use TIA for fixed build-out.
- Lease terms compound: an extra $5,000/month is $60,000/year of EBITDA and roughly $600,000 to $900,000 of enterprise value at a 10x to 15x multiple. Test every concession against margin and exit, not just upfront cash.
Frequently asked questions
How should you finance a healthcare clinic build-out?
Treat it as capital-stack design, not a single funding source. Match the cheapest appropriate capital to each category of spend: a tenant improvement allowance for fixed improvements, equipment or debt financing for recoverable assets like imaging and technology, and equity reserved for growth uses where it earns a better return. The goal is to fund the clinic without spending your most expensive capital on the least strategic assets.
Is a tenant improvement allowance (TIA) free money?
No. A TIA is capital embedded into the lease and repaid over time through occupancy cost. The landlord prices risk, return, and control into the deal, so a large allowance can quietly become one of the most expensive parts of the project. Model the rent burden, lease term, and draw or reimbursement controls before celebrating the headline number.
Should I use equity to fund a clinic build-out?
Usually only as a last resort. Equity is operationally clean because it avoids lender friction, but it's your most expensive capital, and improvements like walls, flooring, and electrical don't generate the return profile that growth investments do. Spending equity there is a dilution-adjacent choice that pulls capital away from patient acquisition, hiring, and operating systems.
How does lease structure affect EBITDA and enterprise value?
Directly, and it compounds. An extra $5,000 per month in rent reduces annual EBITDA by $60,000, and at a 10x to 15x multiple that's roughly $600,000 to $900,000 of enterprise-value pressure. A concession package that looks generous upfront can still be a poor capital decision if it raises occupancy cost and weakens unit economics for the life of the lease.
What should be financed with equipment financing versus TIA?
Use equipment financing for movable, recoverable assets a lender can clearly define and repossess, such as imaging equipment, dental chairs, and technology systems. Use TIA for fixed improvements tied to the shell. Splitting them this way keeps you from funding recoverable equipment with expensive equity or burying it in lease-embedded rent, and it preserves flexibility in the capital stack.
Structure Your Next Clinic Like a Capital Decision
I help healthcare founders align site strategy, lease structure, and build-out financing so expansion supports enterprise value instead of quietly eroding it. We'll walk through:
- Which parts of your build-out should be supported by TIA, debt, or equity
- How your lease structure affects location-level EBITDA and valuation
- Where execution terms can create hidden capital and timeline risk
- How to finance the next site without misusing your most expensive capital
